Anti-VEGF offers comparable benefits in phakic, pseudophakic eyes with AMD

Intravitreal ranibizumab injections for neovascular age-related macular degeneration yielded similar outcomes in phakic and pseudophakic eyes, according to a study.The retrospective review included 120 eyes of 110 patients with neovascular AMD; 75 eyes were phakic and 45 eyes were pseudophakic. Average follow-up was 18 months.

Full Story →